Phase II Trial of Continuous Dose-Intense Temozolomide in Recurrent Malignant Glioma: RESCUE Study At enrollment, the treatment groups had no statistically significant differences in patient ...
Between 2020 and 2025, the papain market expanded from USD 329.7 billion to USD 388.7 billion, reflecting a CAGR of 4.2%. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback